Clearance prediction for Amgen molecules against Extended Clearance Classification System (ECCS) and future...

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Medicinal Chemistry
• Drug Discovery and Development

Background:

• Accurate prediction of drug elimination pathways is crucial for efficient drug discovery.
• The Extended Clearance Classification System (ECCS) offers a framework for identifying major drug elimination routes.
• ECCS aims to guide the development of new chemical entities by predicting their metabolic fate.

Purpose of the Study:

• To critically analyze the chemical space covered by the ECCS framework.
• To assess the applicability and limitations of ECCS in predicting major elimination pathways.
• To evaluate the performance of ECCS using a set of 42 Amgen small molecules.

Main Methods:

• Retrospective analysis of 42 Amgen small molecules using the ECCS framework.
• Evaluation of the ECCS framework's ability to predict the major elimination pathway for these molecules.
• Critical assessment of the chemical space defined by ECCS and its constraints.

Main Results:

• The study assessed the performance of the ECCS framework in retrospectively predicting elimination pathways.
• Analysis revealed constraints and limitations in the chemical space defined by the ECCS.
• The evaluation identified the need for periodic review and revision of the ECCS.

Conclusions:

• The ECCS framework shows potential but requires updates to remain relevant.
• Evolving drug development trends, driven by target constraints, are shifting molecules outside traditional 'drug-like' physicochemical spaces.
• Periodic review and revision of ECCS are essential to maintain its predictive accuracy and applicability in modern drug discovery.